I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

David Seth Cohen net worth and biography

David Cohen Biography and Net Worth

Director of Precipio

David Cohen is Executive Vice President and co-owner of Standard Oil of Connecticut, Inc., the largest independently-owned energy retailing company in Connecticut. David Cohen has also founded a number of highly successful ventures, including: Standard Security Systems, one of the largest electronic security companies in Connecticut; ResCom Energy, a supplier of deregulated electricity in Connecticut, Delaware, Illinois, New Jersey, Ohio, and Pennsylvania; Foresite MSP, a provider of managed security and cyber consulting services; and My Gene Counsel, a cancer bioinformatics company. Mr. Cohen serves on the boards of the following companies: eBrevia, Emme Controls, My Gene Counsel, Sirona Medical Technologies, and The Platt & LaBonia Company. Mr. Cohen holds a BA degree from Harvard College, Class of 1980, and an MBA degree from the Harvard Business School, Class of 1984.

How do I contact David Seth Cohen?: The corporate mailing address for Mr. Cohen and other Precipio executives is 4 Science Park, New Haven CT, 06511. Precipio can also be reached via phone at (203) 787-7888 and via email at [email protected]. Learn More on David Seth Cohen's contact information.
Has David Seth Cohen been buying or selling shares of Precipio?: David Seth Cohen has not been actively trading shares of Precipio during the last ninety days. Most recently, David Seth Cohen sold 3,498 shares of the business's stock in a transaction on Thursday, June 10th. The shares were sold at an average price of $79.80, for a transaction totalling $279,140.40. Learn More on David Seth Cohen's trading history.
Who are Precipio's active insiders?: Precipio's insider roster includes David Cohen (Director), Ilan Danieli (CEO), and Ahmed Sabet (COO). Learn More on Precipio's active insiders.
Are insiders buying or selling shares of Precipio?: In the last year, insiders at the biotechnology company sold shares 1 times. They sold a total of 2,000 shares worth more than $12,560.00. The most recent insider tranaction occured on November, 11th when Director Richard A Sandberg sold 2,000 shares worth more than $12,560.00. Insiders at Precipio own 13.3% of the company. Learn More about insider trades at Precipio.
Information on this page was last updated on 11/11/2024.

David Seth Cohen Insider Trading History at Precipio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/10/2021	Sell	3,498	$79.80	$279,140.40
5/27/2021	Sell	2,008	$79.80	$160,238.40

David Seth Cohen Buying and Selling Activity at Precipio

Precipio Company Overview

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Today's Range

Now: $5.27

$5.22

$5.46

50 Day Range

MA: $6.12

$5.27

$6.65

2 Week Range

Now: $5.27

$4.31

$7.30

Volume

2,600 shs

Average Volume

7,182 shs

Market Capitalization

$7.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

I was wrong. Dead wrong.

From Porter & Company | Ad